Access to insulin delivery devices and glycated haemoglobin in lower-income countries

Table 6 Glycated haemoglobin provision within the 29 countries that had some public health provision

Provision		Measurement methods			Costs per test			Availability
Level (s) of health system settings	Frequency of provision in defined setting	POCT	Laboratory analysis	Both	Number (percentage) providing at no cost to patient	Mean cost to patient (when not provided for free)	Range of cost to patient	Mean availability (when provided)
Primary health care facility	6 (20.7)	3	3	0	2 (33.3)	$10.95	$6.44 (Dominican Republic)-$17.41 (Philippines)	62.5%
District and regional hospitals	27 (93.1)	7	15	5	4 (14.8)	$9.74	$4.00 (Ethiopia and Uzbekistan)-$27.75 (St Lucia)	67.5%
Tertiary hospital	26 (89.7)	4	18	4	9 (34.6)	$11.92	$4.00 (Ethiopia)-$29.00 (Central African Republic)	75.5%

POCT: Point-of-care testing.